Synergistic Protective Effects of Mitochondrial Division Inhibitor 1 and Mitochondria-Targeted Small Peptide SS31 in Alzheimer’s Disease

Journal of Alzheimer's Disease - Netherlands
doi 10.3233/jad-170988
Full Text
Abstract

Available in full text

Date
Authors
Publisher

IOS Press

Related search

Mitochondria in Alzheimer’s Disease

Journal of the Neurological Sciences
Neurology
2019English

Mitochondria and Alzheimer’s Disease

Journal of Neurology & Stroke
2014English

Mitochondrial Division Inhibitor-1 Is Neuroprotective in the A53t-Α-Synuclein Rat Model of Parkinson’s Disease

Scientific Reports
Multidisciplinary
2017English

Synergistic Protective Effects of Antioxidant and Nitric Oxide Synthase Inhibitor in Transient Focal Ischemia

Journal of Cerebral Blood Flow and Metabolism
NeurologyCardiovascular MedicineCardiology
1999English

Characterizing the Protective Effects of SHLP2, a Mitochondrial-Derived Peptide, in Macular Degeneration

Scientific Reports
Multidisciplinary
2018English

Synergistic Effects of Thein cisT251I and P587L Mitochondrial DNA Polymerase Γ Disease Mutations

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2017English

Mitochondrial Targeted Antioxidant Peptide Ameliorates Hypertensive Cardiomyopathy

Journal of the American College of Cardiology
Cardiovascular MedicineCardiology
2011English

Is the A-Beta Peptide of Alzheimer’s Disease an Antimicrobial Peptide?

Journal of Gerontology & Geriatric Research
2014English

Antioxidants Rescue Mitochondrial Transport in Differentiated Alzheimer’s Disease Trans-Mitochondrial Cybrid Cells

Journal of Alzheimer's Disease
GerontologyClinical PsychologyMental HealthPsychiatryGeriatricsMedicineNeuroscience
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy